Bank of America Securities Remains a Buy on McKesson (MCK)
TipRanks (Tue, 21-Jul 4:24 PM ET)
TipRanks (Tue, 21-Jul 4:02 PM ET)
TipRanks (Tue, 21-Jul 3:22 PM ET)
TipRanks (Tue, 21-Jul 3:01 PM ET)
Three themes emerge as AI momentum trade turns volatile: Goldman Sachs
Seeking Alpha News (Sun, 19-Jul 9:01 AM ET)
McKesson Corporation Announces First Quarter Fiscal 2027 Earnings Release Date
Business Wire (Wed, 24-Jun 8:00 AM ET)
Business Wire (Tue, 2-Jun 8:00 AM ET)
Business Wire (Thu, 7-May 4:10 PM ET)
McKesson Corporation Declares Quarterly Dividend
Business Wire (Wed, 22-Apr 8:00 AM ET)
McKesson Plots CFO Transition Amid Record Results and Strategic Realignment
Market Chameleon (Thu, 5-Mar 4:09 AM ET)
McKesson is one of three leading pharmaceutical wholesalers in the US engaged in sourcing and distributing branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospitals networks, and healthcare providers. Along with Cencora and Cardinal Health, the three account for over 90% of the US pharmaceutical wholesale industry. Outside the US market, McKesson engages in pharmaceutical wholesale and distribution in Canada. Additionally, the company supplies medical-surgical products and equipment to healthcare facilities and provides a variety of technology solutions for pharmacies.
Mckesson trades on the NYSE stock market under the symbol MCK.
As of July 21, 2026, MCK stock price declined to $828.84 with 641,112 million shares trading.
MCK has a beta of -0.26, meaning it tends to be less sensitive to market movements. MCK has a correlation of 0.01 to the broad based SPY ETF.
MCK has a market cap of $99.63 billion. This is considered a Large Cap stock.
Last quarter Mckesson reported $96 billion in Revenue and $11.69 earnings per share. This fell short of revenue expectation by $-5 billion and exceeded earnings estimates by $.12.
In the last 3 years, MCK traded as high as $999.00 and as low as $395.30.
The top ETF exchange traded funds that MCK belongs to (by Net Assets): VTI, VOO, IVV, SPY, VTV.
MCK has underperformed the market in the last year with a return of +17.2%, while the SPY ETF gained +20.4%. In the last 3 month period, MCK fell short of the market, returning -3.4%, while SPY returned +5.9%. However, in the most recent 2 weeks MCK has outperformed the stock market by returning +5.7%, while SPY returned -0.4%.
MCK support price is $815.02 and resistance is $847.90 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that MCK shares will trade within this expected range on the day.